Bank of New York Mellon’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.6M Buy
184,109
+37,524
+26% +$2.37M ﹤0.01% 1818
2025
Q1
$7.76M Sell
146,585
-1,661
-1% -$88K ﹤0.01% 1984
2024
Q4
$8.3M Sell
148,246
-680
-0.5% -$38.1K ﹤0.01% 2013
2024
Q3
$7.8M Sell
148,926
-42,945
-22% -$2.25M ﹤0.01% 2065
2024
Q2
$7.88M Buy
191,871
+24,033
+14% +$987K ﹤0.01% 2090
2024
Q1
$7.27M Sell
167,838
-12,384
-7% -$537K ﹤0.01% 2138
2023
Q4
$8.28M Buy
180,222
+2,846
+2% +$131K ﹤0.01% 2079
2023
Q3
$4.07M Sell
177,376
-10,420
-6% -$239K ﹤0.01% 2424
2023
Q2
$3.1M Buy
187,796
+161,070
+603% +$2.66M ﹤0.01% 2593
2023
Q1
$477K Sell
26,726
-5,557
-17% -$99.1K ﹤0.01% 3509
2022
Q4
$940K Sell
32,283
-7,625
-19% -$222K ﹤0.01% 3216
2022
Q3
$978K Buy
39,908
+18,413
+86% +$451K ﹤0.01% 3212
2022
Q2
$89K Sell
21,495
-130,854
-86% -$542K ﹤0.01% 4249
2022
Q1
$1.76M Sell
152,349
-4,569
-3% -$52.7K ﹤0.01% 3009
2021
Q4
$1.57M Buy
156,918
+495
+0.3% +$4.94K ﹤0.01% 3136
2021
Q3
$2.04M Buy
156,423
+16,391
+12% +$214K ﹤0.01% 2958
2021
Q2
$2.74M Buy
140,032
+3,878
+3% +$75.9K ﹤0.01% 2802
2021
Q1
$2.9M Buy
136,154
+5,732
+4% +$122K ﹤0.01% 2712
2020
Q4
$3.88M Buy
130,422
+5,734
+5% +$170K ﹤0.01% 2478
2020
Q3
$2.7M Sell
124,688
-1,618
-1% -$35.1K ﹤0.01% 2505
2020
Q2
$2.82M Buy
126,306
+10,476
+9% +$234K ﹤0.01% 2489
2020
Q1
$1.76M Buy
115,830
+5,890
+5% +$89.6K ﹤0.01% 2616
2019
Q4
$2.52M Buy
109,940
+24,510
+29% +$563K ﹤0.01% 2679
2019
Q3
$1.84M Sell
85,430
-629
-0.7% -$13.6K ﹤0.01% 2794
2019
Q2
$1.89M Buy
86,059
+16,507
+24% +$363K ﹤0.01% 2821
2019
Q1
$1.91M Buy
69,552
+2,464
+4% +$67.5K ﹤0.01% 2795
2018
Q4
$1.8M Buy
67,088
+6,814
+11% +$183K ﹤0.01% 2772
2018
Q3
$1.76M Buy
60,274
+22,481
+59% +$656K ﹤0.01% 2919
2018
Q2
$1.18M Buy
37,793
+13,462
+55% +$421K ﹤0.01% 3159
2018
Q1
$485K Buy
24,331
+6,323
+35% +$126K ﹤0.01% 3597
2017
Q4
$523K Buy
+18,008
New +$523K ﹤0.01% 3594